Skip to content

Clinical trials

Completed Bacterial Infections trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacterial Infections Status: Completed Country / region: Australia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20091
20102
20122
20132
20141
20161
20181
20191
20201
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Qpex Biopharma, Inc.4
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)3
Pfizer2
The University of Queensland2
Andrew Steer1
Bugworks Research Inc.1
Duke University1
Meiji Seika Pharma Co., Ltd.1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacterial Infections21
Cellulitis2
Bacteremia1
COVID-191
Coinfection1
Communicable Diseases1
Diabetes Complications1
Diabetic Foot1
Foot Ulcer1
Gram-Positive Bacterial Infections1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.